Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ATP9A |
| Upstream (Parents) |
|---|
| (<<) PLAGL2 → ATP9A |
| (<<) DDX27 → ATP9A |
| (<<) BCL11A → ATP9A |
| Downstream (Children) |
|---|
| ATP9A → PYGL (>>) |
| ATP9A → H2AFJ (>>) |
| ATP9A → CBFA2T2 (>>) |
| ATP9A → KRT23 (>>) |
| ATP9A → COL9A3 (>>) |
| ATP9A → SRC (>>) |
| ATP9A → DAPK2 (>>) |
| ATP9A → CD70 (>>) |
| ATP9A → ZNF177 (>>) |
| ATP9A → STRN3 (>>) |
| ATP9A → MEFV (>>) |
| ATP9A → POU5F1P3 (>>) |
| ATP9A → FKBP11 (>>) |
| ATP9A → CAMK2N1 (>>) |
| ATP9A → PELI2 (>>) |
| ATP9A → PLCG1 (>>) |
